RYTM logo

Rhythm Pharmaceuticals, Inc. (RYTM)

Profile

Full Name

Rhythm Pharmaceuticals, Inc.

Ticker

NASDAQ: RYTM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 9, 2017

Indexes

Not included

Website

http://rhythmtx.com

Employees

283

Key Details

Price

$84.66(-1.13%)

Market cap

$5.59B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$130.13M(+68.06% YoY)

Annual EPS

-$4.34(-35.62% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $84.66
    RYTM price is $84.66

    30-Day Relative Volume

    0.61
    RYTM 30-day relative volume is 0.61

    Price Performance

    Price Most recent change

    -1.13%
    RYTM price was down -1.13% on Jul 30, 2025

    Price YTD change

    +51.23%
    RYTM price is up +51.23% since January 1st

    Price 1-year change

    +77.63%
    RYTM price is up +77.63% year-on-year

    Price 3-year change

    +571.9%
    RYTM price is up +571.9% over the past 3 years

    Price Range

    Price All-time high

    $94.80
    RYTM price is currently -10.70% below its historical high of $94.80

    Price 3-year low

    $12.18
    RYTM price is currently +595.07% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.59B
    RYTM market capitalization is $5.59 billion

    Market cap 3-year change

    +774.17%
    RYTM market capitalization is up +774.17% over the past 3 years

    Market cap All-time high

    $6.03B
    RYTM market capitalization is currently -7.41% below its historical high of $6.03 billion

    Market cap sector rank

    89.36%
    RYTM market capitalization is higher than 89.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +7.95%
    RYTM shares outstanding is up +7.95% year-on-year

    Shares Outstanding 3-Year Change

    +30.1%
    RYTM shares outstanding is up +30.1% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.88
    RYTM beta is 0.88

    200-day SMA

    $60.27
    RYTM price is currently +40.46% above its 200-day simple moving average

    50-day SMA

    $71.36
    RYTM price is currently +18.63% above its 50-day simple moving average

    RSI

    61.41
    RYTM 14-day relative strength index is 61.41

    Volume

    0.61
    RYTM 30-day relative volume is 0.61

    ATR

    $2.74
    RYTM average true range is $2.74

    10-day Historical Volatility

    7.59%
    RYTM 10-day historical volatility is 7.59%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $130.13M
    RYTM annual revenue is $130.13 million

    Revenue Analysts estimate

    $175.87M
    RYTM annual revenue is currently -26.01% lower than the consensus analysts' forecast

    Revenue 1-year change

    +68.06%
    RYTM annual revenue is up +68.06% year-on-year

    Revenue Sector rank

    58.7%
    RYTM annual revenue is higher than 58.7% of companies in Healthcare sector

    EPS

    EPS

    -$4.34
    RYTM annual earnings per share is -$4.34

    EPS Analysts estimate

    -$2.84
    RYTM annual earnings per share is currently +52.82% higher than the consensus analysts' forecast

    EPS 1-year change

    -35.62%
    RYTM annual earnings per share is down -35.62% year-on-year

    EPS Sector rank

    22.78%
    RYTM annual earnings per share is higher than 22.78% of companies in Healthcare sector

    Profit

    Gross profit

    $116.76M
    RYTM annual gross profit is $116.76 million

    Gross margin

    89.73%
    RYTM annual gross profit margin is 89.73%

    Operating profit

    -$265.50M
    RYTM annual operating income is -$265.50 million

    Operating margin

    -204.04%
    RYTM annual operating profit margin is -204.04%

    Net income

    -$260.60M
    RYTM annual net profit is -$260.60 million

    Net margin

    -200.27%
    RYTM annual net profit margin is -200.27%

    Expenses

    Total expenses

    $395.63M
    RYTM annual total expenses is $395.63 million

    Operating expenses

    $382.26M
    RYTM annual total operating expenses is $382.26 million

    Cost of goods sold

    $13.37M
    RYTM annual cost of goods sold is $13.37 million

    Selling, general & administrative expenses

    $144.30M
    RYTM annual SGA is $144.30 million

    Depreciation and amortization

    $1.56M
    RYTM annual depreciation & amortization is $1.56 million

    Interest expense

    $20.60M
    RYTM annual interest expense is $20.60 million

    Income tax

    $346.00K
    RYTM annual income tax is $346.00 thousand

    EBIT & EBITDA

    EBIT

    -$239.65M
    RYTM annual earnings before interest & taxes is -$239.65 million

    EBITDA

    -$238.09M
    RYTM annual EBITDA is -$238.09 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $392.27M
    RYTM annual total assets is $392.27 million

    Non current assets

    $18.07M
    RYTM annual long term assets is $18.07 million

    Current assets

    $374.20M
    RYTM annual total current assets is $374.20 million

    Cash and cash equivalents

    $89.14M
    RYTM annual cash & cash equivalents is $89.14 million

    Accounts receivable

    $18.51M
    RYTM annual accounts receivable is $18.51 million

    Inventory

    $18.74M
    RYTM annual inventory is $18.74 million

    Liabilities

    Total liabilities

    $227.72M
    RYTM annual total liabilities is $227.72 million

    Long term liabilities

    $112.21M
    RYTM annual total long term liabilities is $112.21 million

    Current liabilities

    $115.52M
    RYTM annual total current liabilities is $115.52 million

    Accounts payable

    $12.33M
    RYTM annual accounts payable is $12.33 million

    Debt

    Total debt

    $3.94M
    RYTM annual total debt is $3.94 million

    Total debt 1-year change

    +212.54%
    RYTM annual total debt is up +212.54% year-on-year

    Long term debt

    $3.94M
    RYTM annual long term debt is $3.94 million

    Short term debt

    $0.00
    RYTM annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $164.55M
    RYTM annual stockholders equity is $164.55 million

    Book value

    $21.73M
    RYTM annual book value is $21.73 million

    Retained earnings

    -$1.16B
    RYTM annual retained earnings is -$1.16 billion

    Working capital

    $258.68M
    RYTM annual working capital is $258.68 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$113.88M
    RYTM annual cash flow from operations is -$113.88 million

    Cash from operations 1-year change

    +16.36%
    RYTM annual cash flow from operations is up +16.36% year-on-year

    Cash from investing

    -$48.17M
    RYTM annual cash flow from investing activities is -$48.17 million

    Cash from investing 1-year change

    -750.36%
    RYTM annual cash flow from investing activities is down -750.36% year-on-year

    Cash from financing

    $191.24M
    RYTM annual cash flow from financing activities is $191.24 million

    Cash from financing 1-year change

    +157.16%
    RYTM annual cash flow from financing activities is up +157.16% year-on-year

    CAPEX

    CAPEX

    -
    RYTM annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    RYTM annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$113.88M
    RYTM annual free cash flow is -$113.88 million

    Free cash flow 1-year change

    +16.39%
    RYTM annual free cash flow is up +16.39% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    89.73%
    RYTM annual gross profit margin is 89.73%

    Operating margin

    -204.04%
    RYTM annual operating profit margin is -204.04%

    Net margin

    -200.27%
    RYTM annual net profit margin is -200.27%

    ROA & ROE

    ROA

    -71.89%
    RYTM annual return on assets is -71.89%

    ROE

    -155.91%
    RYTM annual return on equity is -155.91%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RYTM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RYTM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    294.86
    RYTM price to book ratio is 294.86

    PB ratio Sector rank

    99.75%
    RYTM price to book ratio is higher than 99.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    40.82
    RYTM price to sales ratio is 40.82

    PS ratio Sector rank

    89.33%
    RYTM price to sales ratio is higher than 89.33% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.48B
    RYTM enterprise value is $5.48 billion

    Enterprise value Sector rank

    88.89%
    RYTM enterprise value is higher than 88.89% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -37.48
    RYTM EV/EBITDA is -37.48

    EV/EBITDA Sector rank

    4.67%
    RYTM EV/EBITDA is higher than 4.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.24
    RYTM annual current ratio is 3.24

    Quick ratio

    3.08
    RYTM annual quick ratio is 3.08

    Leverage

    Debt to equity

    0.00
    RYTM annual debt to equity ratio is 0.00

    Interest coverage ratio

    -11.63
    RYTM annual interest coverage ratio is -11.63

    Risk & Stability

    Piotroski F-Score

    2
    RYTM piotroski f-score is 2

    Altman Z-Score

    9.70
    RYTM altman z-score is 9.70

    Analyst ratings

    Recent major analysts updates

    Jul 18, 25 Canaccord Genuity
    Buy
    Jul 10, 25 Wells Fargo
    Overweight
    Jul 10, 25 Oppenheimer
    Outperform
    Jul 10, 25 Leerink Partners
    Outperform
    Jul 10, 25 B of A Securities
    Buy
    Jul 9, 25 Needham
    Buy
    Jul 7, 25 Leerink Partners
    Outperform
    Jun 26, 25 JMP Securities
    Market Outperform
    May 29, 25 Stifel
    Buy
    May 7, 25 Needham
    Buy

    Institutional Ownership

    Screeners with RYTM included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Rhythm Pharmaceuticals, Inc.?
    • Does Rhythm Pharmaceuticals, Inc. pay dividends?
    • What sector is Rhythm Pharmaceuticals, Inc. in?
    • What industry is Rhythm Pharmaceuticals, Inc. in?
    • What country is Rhythm Pharmaceuticals, Inc. based in?
    • When did Rhythm Pharmaceuticals, Inc. go public?
    • Is Rhythm Pharmaceuticals, Inc. in the S&P 500?
    • Is Rhythm Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Rhythm Pharmaceuticals, Inc. in the Dow Jones?
    • When was Rhythm Pharmaceuticals, Inc.'s last earnings report?
    • When does Rhythm Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Rhythm Pharmaceuticals, Inc.?

    The ticker symbol for Rhythm Pharmaceuticals, Inc. is NASDAQ:RYTM

    Does Rhythm Pharmaceuticals, Inc. pay dividends?

    No, Rhythm Pharmaceuticals, Inc. does not pay dividends

    What sector is Rhythm Pharmaceuticals, Inc. in?

    Rhythm Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Rhythm Pharmaceuticals, Inc. in?

    Rhythm Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Rhythm Pharmaceuticals, Inc. based in?

    Rhythm Pharmaceuticals, Inc. is headquartered in United States

    When did Rhythm Pharmaceuticals, Inc. go public?

    Rhythm Pharmaceuticals, Inc.'s initial public offering (IPO) was on October 9, 2017

    Is Rhythm Pharmaceuticals, Inc. in the S&P 500?

    No, Rhythm Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Rhythm Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Rhythm Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Rhythm Pharmaceuticals, Inc. in the Dow Jones?

    No, Rhythm Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Rhythm Pharmaceuticals, Inc.'s last earnings report?

    Rhythm Pharmaceuticals, Inc.'s most recent earnings report was on May 7, 2025

    When does Rhythm Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Rhythm Pharmaceuticals, Inc. is August 5, 2025
    On this page